Saint Cyr l'Ecole, France

Nicolas Iscolo

This inventor holds 2 USPTO granted patents. Top assignee: Ela Medical S.a.. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 103(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Cardiac Devices by Nicolas Iscolo

Introduction

Nicolas Iscolo is a prominent inventor based in Saint Cyr l'Ecole, France. He has made significant contributions to the field of medical technology, particularly in the development of advanced cardiac devices. With a total of 2 patents, Iscolo's work focuses on improving the detection and treatment of tachyarrhythmias.

Latest Patents

Iscolo's latest patents include a "Method and apparatus for advanced tachyarrhythmia discrimination" and "Methods and apparatus for improved tachycardia discrimination." The first patent describes an active implantable medical device designed to monitor atrial and ventricular activity. This device can classify tachycardia episodes and determine the appropriate therapy, such as defibrillation or anti-tachycardia stimulation. The second patent enhances the discrimination capabilities of the device, allowing for better identification of tachycardias and the delivery of targeted therapies based on the analysis of RR and PR intervals.

Career Highlights

Nicolas Iscolo is associated with Ela Medical S.A., a company known for its innovative medical devices. His work has been instrumental in advancing the technology used in defibrillators and cardioverters, contributing to improved patient outcomes in cardiac care.

Collaborations

Iscolo has collaborated with notable colleagues, including Marcel Limousin and Remi Nitzsche. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of medical technology.

Conclusion

Nicolas Iscolo's contributions to cardiac device technology exemplify the impact of innovation in healthcare. His patents reflect a commitment to enhancing the effectiveness of medical treatments for tachyarrhythmias, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…